New-onset pelvic organ prolapse after Novasure endometrial ablation.

Department of Obstetrics and Gynecology, Baystate Medical Center, 759 Chestnut Street, Springfield, MA 01199, USA.
Archives of Gynecology and Obstetrics (Impact Factor: 1.36). 09/2008; 278(2):187-9. DOI: 10.1007/s00404-007-0546-7
Source: PubMed


Endometrial ablation with bipolar radiofrequency energy (NovaSure) for dysfunctional uterine bleeding has gained wide acceptance due to its ease and efficacy.
A 45-year-old, gravida three, para two, female developed symptomatic Stage 3 pelvic organ prolapse (POP) 1 month after endometrial ablation using NovaSure.
To our knowledge, this is the first published case of new-onset POP briefly after an endometrial ablation. It is not clear whether there is a causal association between the ablation procedure and de novo POP. Should there be any additional cases of de novo POP post endometrial ablation, further investigation would be warranted.

168 Reads
  • [Show abstract] [Hide abstract]
    ABSTRACT: To investigate the number and type of complications associated with global endometrial ablation using public-access governmental databanks. MEDLINE (PubMed) and the US Food and Drug Administration Manufacturer and User Facility Device Experience (MAUDE) databases were searched for entries for the four US Food and Drug Administration-approved global endometrial ablation devices. Traditional MEDLINE and bibliography searches yielded reports of two cases of hemorrhage, one case of pelvic inflammatory disease, 20 cases of endometritis, two cases of first-degree skin burns, nine cases of hematometra, and 16 cases of vaginitis and/or cystitis. A search of the US Food and Drug Administration MAUDE database yielded reports of 85 complications in 62 patients. These included major complications: eight cases of thermal bowel injury, 30 cases of uterine perforation, 12 cases in which emergent laparotomy was required, and three intensive care unit admissions. One patient developed necrotizing fasciitis and eventually underwent vulvectomy, ureterocutaneous ostomy, and bilateral below-the-knee amputations. One of the patients with thermal injury to the bowel died. Use of the US Food and Drug Administration MAUDE database is helpful in identifying serious complications associated with global endometrial ablation not yet reported in the medical literature.
    Obstetrics and Gynecology 01/2004; 102(6):1278-82. DOI:10.1016/j.obstetgynecol.2003.07.007 · 5.18 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: New technologies available for the treatment of idiopathic menorrhagia include five global endometrial ablation devices that use differing ablative methods, including thermal balloon, circulated hot fluid, cryotherapy, radiofrequency electrosurgery, and microwave energy. All have been compared with rollerball endometrial ablation by way of randomized clinical trials and are associated with high patient satisfaction rates, regardless of method, but a wide range of amenorrhea rates (13.9-55.3%). They are associated with low complication rates when performed by well-trained physicians following protocols in Food and Drug Administration trials. Some serious complications have been reported subsequently. Strict adherence to patient selection criteria and manufacturer protocols is strongly recommended. New technologies for the treatment of uterine leiomyomata include uterine artery embolization, magnetic resonance-guided focused ultrasonography, laparoscopic uterine artery occlusion, and cryomyolysis. There is sound evidence for shorter hospital stay, quicker return to work, and a similar major complication rate compared with hysterectomy. Uterine artery embolization appears to be effective for up to 5 years in reducing bulk symptoms and menorrhagia associated with leiomyomata. The chance of reoperation for leiomyoma-related symptoms within 5 years is 20-29%. Women who wish to become pregnant should be cautioned about potential complications during pregnancy. There is insufficient evidence to recommend uterine artery embolization in postmenopausal women. With regard to magnetic resonance-guided focused ultrasonography, cryomyolysis, and laparoscopic uterine artery occlusion, although the initial symptom reduction outcomes have been reported as favorable, more data are needed to better understand the durability of these results.
    Obstetrics and Gynecology 11/2006; 108(4):990-1003. DOI:10.1097/01.AOG.0000232618.26261.75 · 5.18 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Uterine artery embolization (UAE) is gaining popularity as a treatment modality in patients with symptomatic uterine fibroids who do not desire fertility. Complications of this procedure can be serious and disabling. A 50-year-old woman presented with stage II uterovaginal prolapse after UAE for symptomatic uterine fibroids. Pelvic organ prolapse developed 16 months after the initial procedure. Surgical correction was performed. This is the first case report of pelvic organ prolapse after UAE. Normal prior gynecological examinations, and absence of pelvic pressure symptoms, indicate that pelvic organ prolapse had occurred subsequent to UAE.
    International Urogynecology Journal 05/2004; 15(3):214-5. DOI:10.1007/s00192-004-1140-1 · 1.96 Impact Factor